«Malnutrition

Below is an extended Malnutrition patents listing. Click here to return to the Malnutrition main in depth entry.

Patents :
US Patent No.	Title
7381409	Antibodies specific for sclerostin and methods of screening and use therefor
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396525	Care/makeup compositions comprising a 2-alkylideneaminooxyacetamide compound for stimulating the growth of the hair or eyelashes and/or slowing loss thereof
7396654	Neural proteins as biomarkers for traumatic brain injury
7396819	Anthelmintic formulations
7396820	Anthelmintic formulations
7396829	Nitric oxide enhancing diuretic compounds, compositions and methods of use
7399492	Composition and method for issue repair and regeneration
7399829	Variants of RANKL protein
7402405	Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
7402564	Synthetic peptide amides
7390894	Glutathione S-transferase sequence variants
7390637	Keratinocyte derived interferon
7381701	Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
7381792	Variants of RANKL protein
7381800	Antibodies to HBIMF63 polypeptide
7381848	Estrogenic compounds as anti-mitotic agents
7381910	Sensor frame for generating a weight signal of a curved object
7385025	Metallopeptide compounds
7385065	Derivatives of asimadoline with covalently bonded acids
7390417	Portable ultraviolet water purification system
7390509	Compositions and methods for nutrition supplementation
7390519	Probiotic Lactobacillus salivarius strains
7402571	Methods and pharmaceutical compositions for healing wounds
7404950	Induced activation in dendritic cell
7404976	Method of administering a milk substitute to critical care animals
7422555	Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
7422764	Matrix-forming composition containing pectin
7422847	Human E3.alpha. ubiquitin ligase family
7423019	Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
7423057	Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
7425323	Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
7425622	Antibodies against C3a receptor
7427397	Probiotic propionibacterium
7427619	Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7420033	Composition of lactoferrin related peptides and uses thereof
7419781	Human antibiotic proteins
7405193	Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation
7407526	Food additive
7407953	Wound healing
7407976	Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
7409297	Methods and systems for providing a nutraceutical program specific to an individual animal
7411051	Antibodies to HDPPA04 polypeptide
7415734	Thermally-insulative, breast-supportive undergarment
7416094	Dinnerware with attached figure and diet reminder
7417038	Methods of treating cachexia
7417121	Human G-protein coupled receptor, HGPRBMY39
7429646	Antibodies to human tumor necrosis factor receptor-like 2

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.